Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer

Clinical trial NCT00365183 · TERMINATED

Trial details

NCT number: NCT00365183
Sponsor: Pharmacyclics LLC.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Carcinoma

Start date: 2006-06-01
Primary completion: 2008-01-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.